QUAMED is proud to announce that we have issued the first 2 QCP certificates. Our Independent Decision Committee (IDC) has issued a QCP GSDP certificate to BaDM, a pharmaceutical distributor based in Ukraine. The IDC has also issued a QCP MQAS certificate to Imres, an international pharmaceutical distributor based in the Netherlands. The certificate register ...
QUAMED is happy to announce that its board of directors has accepted the Medical Export Group membership applications (in the Netherlands) and CHMP (in Kenya) as adherent members of our association. The board has also accepted the application of Mr. George Mugi as an associative member. We have been working and communicating with all three ...
The recent Bloomberg post by Kendall Taggart and Priyanka Pulla highlights the tragic consequences of compromised drug manufacturing, specifically focusing on an Indian pharmaceutical supplier, Naprod Life Sciences. The narrative revolves around an investigative report shedding light on the distressing aftermath of contaminated medications distributed by Naprod. In Colombia, four children lost their lives, and over a hundred ...
Medical Product Alert N°8/2023 Substandard (contaminated) syrup and suspension medicines have been identified in multiple WHO regions, including the Americas, Eastern Mediterranean, Southeast Asia, and the Western Pacific. Five products from PHARMIX LABORATORIES (PVT.) LTD, including ALERGO Syrup and ULCOFIN Suspension, have been found with dangerous levels of ethylene glycol, posing severe health risks like ...
The E-Drug Community is thrilled to reintroduce E-Drug as E-Drug Plus, aiming to offer the same engagement opportunities as before! By registering at https://talk.edrugplus.org/login and resetting your password using your previous email, you’ll regain access to the familiar email digests and enjoy interactive features on the new platform. Dive back into the community and stay informed! ...
This week, we had the privilege to participate in the 2023 Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers in Copenhagen. It was an opportunity to learn from colleagues about the latest developments around the UN organisations’ approach to pharmaceutical quality assurance and procurement. The session on Regulatory Updates was especially interesting. It ...
Last week, QUAMED participated in the second formal meeting of the CIP Global Steering Group (GSG) held on 9-10th November 2023 in the Hague, Netherlands. CIP (Coalition of Interested Parties) is a network for regulatory systems strengthening established by the World Health Organization (WHO) to promote a unified, strategic and coordinated approach to national and ...
The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Dear Friends, After a few ‘silent’ weeks, I would like to share with you three papers, all somehow related to antibiotic quality and/or rational use. Depending on your personal interests and background in the related disciplines, you ...
Exciting news from our recent Board of Directors meeting on September 29-30, 2023! We’re thrilled to welcome Concern Worldwide as an associative member and AMEX Healthcare GmBH as an adherent member. Our Strategic Business Plan for 2024-2026 is in progress, and we’ll be seeking your input soon. Stay tuned for updates on the QUAMED Technical ...
The QUAMED board of directors had its annual in-person meeting in Brussels last week. We are pleased to announce that the board of directors has appointed Dr. Patrick Lukulay, Ph.D. as President of our association. In that capacity, he will chair the QUAMED board of directors. He is replacing Daniel Vandenbergh who has been the ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.